Back to Search Start Over

Enhanced 15-Lipoxygenase 1 Production is Related to Periostin Expression and Eosinophil Recruitment in Eosinophilic Chronic Rhinosinusitis

Authors :
Masafumi Sakashita
Tetsuji Takabayashi
Yukinori Kato
Yoshimasa Imoto
Masanori Kidoguchi
Kazuhiro Ogi
Kanako Yoshida
Yumi Ito
Norihiko Narita
Yukihiro Kimura
Naoto Adachi
Keisuke Koyama
Masayuki Okamoto
Shigeharu Fujieda
Masafumi Kanno
Source :
Biomolecules, Volume 10, Issue 11
Publication Year :
2020
Publisher :
MDPI AG, 2020.

Abstract

Background: The pathological features of chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) tissues include an eosinophilic infiltration pattern (eosinophilic CRS (ECRS)) or a less eosinophilic pattern (non-ECRS). Recently, it has been suggested that 15-lipoxygenase 1 (15-LOX-1) may have significant roles in allergic disease<br />however, the significance of 15-LOX-1 in CRS is not well understood. The objective of this study was to demonstrate the expression of 15-LOX-1 in CRS. Methods: The mRNA expression levels of 15-LOX-1 and periostin in nasal tissues were measured by quantitative real-time polymerase chain reaction. We also performed an immunofluorescence study of nasal tissues. Cells of the Eol-1 eosinophilic leukemic cell line were stimulated with interleukin-33 to test the induction of 15-LOX-1. Results: The expression level of 15-LOX-1 mRNA in nasal polyps (NPs) was significantly higher in ECRS patients than in non-ECRS patients. The immunofluorescence study revealed that both airway epithelial cells and eosinophils in NPs expressed 15-LOX-1. A significant correlation was seen between the number of eosinophils and the mRNA expression levels of 15-LOX-1 and periostin in nasal polyps. Moreover, interleukin-33 enhanced 15-LOX-1 expression in Eol-1 cells. Conclusions: 15-LOX-1 was shown to be a significant molecule that facilitates eosinophilic inflammation in ECRS.

Details

ISSN :
2218273X
Volume :
10
Database :
OpenAIRE
Journal :
Biomolecules
Accession number :
edsair.doi.dedup.....6489fcf9859fda5cf553bc270d953664